Abstract _ Full Text (HTML) _ Full Text (PDF) _ Review and Revision

Review

Cancer Research Frontiers. 2015 Apr; 1(2): 127-137. doi: 10.17980/2015.127

Managing Advanced Melanoma: Targeting the PD-1 Pathway with Pembrolizumab

Sylvana Ho1, In S. Kang2, Marcus C Ravnan1*

 

1Thomas J Long School of Pharmacy & Health Sciences, University of the Pacific, Stockton, California.

2UC Davis Health System, Sacramento, California.

*Corresponding author: Marcus C Ravnan, Pharm.D., FCSHP, FASHP. Professor, Department of Pharmacy Practice, Thomas J Long School of Pharmacy & Health Sciences, University of the Pacific, Stockton, California. 3601 Pacific Avenue Stockton California 95211. Email: mravnan@pacific.edu

Citation: Ho S, et al. Managing Advanced Melanoma: Targeting the PD-1 Pathway with Pembrolizumab. Cancer Research Frontiers. 2015 Apr; 1(2): 127-137. doi: 10.17980/2015.127

Copyright: @ 2015 Ho S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Competing Interests: The authors declare that they have no competing interests.

Received December 26, 2014; Revised March 25, 2015; Accepted April 1, 2015.

 

Reviewers comments

Answers to reviewers

Revision

 

 

 

 

 

 

Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann